founders behind Quit Genius.Substance abuse has been a consistent and growing problem for decades. Within the U.S., it’s now estimated to impact nearly 21 million Americans, according to statistics from the. For Yusuf Sherwani and his fellow physicians Maroof Ahmed and Sarim Siddiqui, it was hard to watch their patients try to get help for addictions in an environment where it was easy to get diagnosed, but much harder to get connected to treatment.
The U.K. and New York-based company raised a $64 million Series B round co-led by Swedish asset manager Kinnevik and British VC firm Atomico, with participation from existing investors Triple Point Ventures, Octopus Ventures and Startup Health, as originally reported in. Georgi Ganev, the CEO of Kinnevik, says that they were attracted to the company because of its B2B2C approach, which he’s seen successfully play out through the firm’s past investment in Livongo, a diabetes detection company.
With accessibility in mind, Quit Genius opted to focus on a digital platform rooted in connections with real doctors back in 2017. “We are increasingly finding that [patients] do want to receive virtual treatment but know there is a human on the other end,” Sherwani says. Such an approach allows a patient to conduct weekly sessions with a doctor, while also accessing digital tools and chat features that nudge or support them in the interim.
Patients are only charged when they see results, the CEO says. One thing that sets Quit Genius apart: the success of its treatment programs. The startup has conducted multiple peer-reviewed studies so far, including a 12-month controlled study of tobacco treatment that Sherwani says outperformed solely face-to-face sessions. “While we were trying to prove we were just as good, it was significantly better than usual care,” Sherwani says.
Pegasusterroristinindia ModiTerrorist government led in India,why shouldn't this be considered 'espionage'bythe government? salman7khurshid MahuaMoitra Jairam_Ramesh LizThrossell ShashiTharoor my phone hacked on20jun2020,data stolen KapilSibal
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Quit Genius Raises $64 Million For Its Addiction Treatment Telehealth StartupThe company offers B2B2C treatment programs for tobacco, alcohol and opioid addictions and is backed by studies proving that the system works. good luck Merci beaucoup B2L
Source: Forbes - 🏆 394. / 53 Read more »
Quit Genius Raises $64 Million For Its Addiction Treatment Telehealth StartupThe company offers B2B2C treatment programs for tobacco, alcohol and opioid addictions and is backed by studies proving that the system works. thanks 🔥요한계시록 11장 두 증인의 메가 글로벌 수요예배 안내🔥 * 한국시간 🇰🇷 2021년 7월 22일 2PM [동시통역 생중계 채널] 유튜브: 페이스북: 회개와_거룩함 메시아께서_오신다 ProphetDrOwuor 휴거_환난
Source: Forbes - 🏆 394. / 53 Read more »
95% Of People Want To Quit Their Jobs Because Of Stress – Here's How To Combat Work Burnout95% of American workers are now questioning whether or not they should quit their jobs because of work burnout. Here's what you can do.
Source: Gossip Cop - 🏆 398. / 53 Read more »
Quit Genius Raises $64 Million For Its Addiction Treatment Telehealth StartupThe company offers B2B2C treatment programs for tobacco, alcohol and opioid addictions and is backed by studies proving that the system works. good luck Merci beaucoup B2L
Source: Forbes - 🏆 394. / 53 Read more »
Quit Genius Raises $64 Million For Its Addiction Treatment Telehealth StartupThe company offers B2B2C treatment programs for tobacco, alcohol and opioid addictions and is backed by studies proving that the system works. thanks 🔥요한계시록 11장 두 증인의 메가 글로벌 수요예배 안내🔥 * 한국시간 🇰🇷 2021년 7월 22일 2PM [동시통역 생중계 채널] 유튜브: 페이스북: 회개와_거룩함 메시아께서_오신다 ProphetDrOwuor 휴거_환난
Source: Forbes - 🏆 394. / 53 Read more »
This Startup Raised $30 Million To Create Brain Maps To Aid Surgeries And TherapeuticsI am a New York based health and science reporter and a graduate from Columbia’s School of Journalism with a master's in science and health reporting. I write on infectious diseases, global health, gene editing tools, intersection of public health and global warming. Previously, I worked as a health reporter in Mumbai, India, with the Hindustan Times, a daily newspaper where I extensively reported on drug resistant infections such as tuberculosis, leprosy and HIV. I also reported stories on medical malpractice, latest medical innovations and public health policies. I have a master’s in biochemistry and a bachelor’s degree in zoology. My experience of working in a molecular and a cell biology laboratory helped me see science from researcher's eye. In 2018 I won the EurekAlert! Fellowships for International Science Reporters. My Twitter account aayushipratap
Source: Forbes - 🏆 394. / 53 Read more »